Overview

Comparison of Ticagrelor vs. Prasugrel on Inflammation, Arterial Stiffness, Endothelial Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting

Status:
Completed

Trial end date:
2017-01-01

Target enrollment:

Participant gender:

Summary

To investigate pleiotropic effects of ticagrelor in addition to its antiplatelet effects in type 2 diabetic patients with non-ST elevation acute coronary syndrome by measuring inflammatory markers, circulating number of endothelial progenitor cells, brachial artery endothelial function, and arterial stiffness.

Phase:

Phase 4

Details

Lead Sponsor:

Korea University Anam Hospital

Collaborator:

AstraZeneca

Treatments:

Prasugrel Hydrochloride
Ticagrelor